Research Article

Kaji-Ichigoside F1 and Rosamultin Protect Vascular Endothelial Cells against Hypoxia-Induced Apoptosis via the PI3K/AKT or ERK1/2 Signaling Pathway

Figure 7

Kaji-ichigoside F1 decreased cell apoptotic rates via ERK1/2 signaling pathway activation, and Rosamultin decreased cell apoptotic rates via PI3K/AKT and ERK1/2 signaling pathway activation during hypoxia. (a) FACS analysis of apoptosis. (b) Cell apoptotic rate by FACS. The percentage of apoptotic cells is shown as (). + vs. normoxia control group, , ++ vs. model group, # vs. Kaji-ichigoside F1 group. & vs. Rosamultin group.
(a)
(b)